Tech Company Financing Transactions
Antegrin Therapeutics Funding Round
Private investors participated in a $595.6 thousand venture round for Antegrin Therapeutics. The round was recorded on 10/2/2015.
Transaction Overview
Company Name
Announced On
10/2/2015
Transaction Type
Venture Equity
Amount
$595,618
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing. Amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities or debt.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
4320 Forest Park Ave. 304
St. Louis, MO 63108
USA
St. Louis, MO 63108
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Antegrin Therapeutics is a pharmaceutical company dedicated to the development of novel therapies for fibrotic diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Robert Karr
Chief Scientific Officer
Peter Ruminski
Co-Founder
David Griggs
Browse more venture capital transactions:
Prev: 10/1/2015: ORIGO Education venture capital transaction
Next: 10/2/2015: ZeeMee venture capital transaction
Share this article
About Database of VC Transactions
We do our best to record every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs